Patents by Inventor George Tidmarsh

George Tidmarsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for administering angiotensin II
    Patent number: 11583568
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: February 21, 2023
    Assignee: La Jolla Pharma, LLC
    Inventors: Lakhmir Chawla, George Tidmarsh, Steve Ching Tsung Chen
  • COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE
    Publication number: 20220193183
    Abstract: The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of renal failure, especially renal failure associated with cirrhosis.
    Type: Application
    Filed: July 30, 2021
    Publication date: June 23, 2022
    Inventor: George TIDMARSH
  • Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II
    Patent number: 11219662
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: January 11, 2022
    Assignee: La Jolla Pharma, LLC
    Inventors: George Tidmarsh, Lakhmir Chawla
  • METHODS FOR ADMINISTERING ANGIOTENSIN II
    Publication number: 20210187058
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Application
    Filed: March 4, 2021
    Publication date: June 24, 2021
    Inventors: George Tidmarsh, Lakhmir Chawla
  • METHODS OF ADMINISTERING HEPCIDIN
    Publication number: 20210128690
    Abstract: The present disclosure relates to the use of hepcidin in therapeutic methods for the treatment of various conditions in which decreasing serum iron concentration may be beneficial.
    Type: Application
    Filed: December 19, 2017
    Publication date: May 6, 2021
    Inventors: Lakhmir Chawla, George Tidmarsh
  • METHODS FOR ADMINISTERING ANGIOTENSIN II
    Publication number: 20210030834
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Application
    Filed: March 26, 2020
    Publication date: February 4, 2021
    Inventors: George Tidmarsh, Lakhmir Chawla
  • METHODS FOR TREATING HYPOTENSION
    Publication number: 20200237853
    Abstract: The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Application
    Filed: April 17, 2020
    Publication date: July 30, 2020
    Inventors: George Tidmarsh, Lakhmir Chawla
  • METHODS FOR ADMINISTERING ANGIOTENSIN II
    Publication number: 20200222493
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Application
    Filed: April 13, 2018
    Publication date: July 16, 2020
    Inventors: Lakhmir Chawla, George Tidmarsh, Steve Ching Tsung Chen
  • COMPOSITIONS AND METHODS FOR TREATING IRON OVERLOAD
    Publication number: 20190336583
    Abstract: The present disclosure relates to the use of hepcidin, mini-hepcidin, or a hepcidin analogue in therapeutic methods for the treatment and/or prevention of acquired iron overload or other conditions for which iron redistribution or sequestration is helpful.
    Type: Application
    Filed: January 18, 2018
    Publication date: November 7, 2019
    Inventors: George Tidmarsh, Lakhmir Chawla
  • Methods for administering angiotensin II
    Patent number: 10406201
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: September 10, 2019
    Assignee: La Jolla Pharma, LLC
    Inventors: George Tidmarsh, Lakhmir Chawla
  • METHODS OF ADMINISTERING HEPCIDIN
    Publication number: 20190240292
    Abstract: The present disclosure relates to the use of hepcidin in therapeutic methods for the treatment of various conditions in which decreasing serum iron concentration may be beneficial.
    Type: Application
    Filed: March 21, 2019
    Publication date: August 8, 2019
    Inventors: George Tidmarsh, Lakhmir Chawla
  • METHODS FOR TREATING HYPOTENSION
    Publication number: 20180311306
    Abstract: The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Application
    Filed: June 22, 2018
    Publication date: November 1, 2018
    Inventors: George Tidmarsh, Lakhmir Chawla
  • METHODS OF TREATING IRON OVERLOAD
    Publication number: 20180099023
    Abstract: Provided herein are compositions and methods related to the use of hepcidin and/or hepcidin analogues for the treatment and/or prevention of iron overload in a subject (e.g., a human subject) and/or for reducing serum iron levels in a subject without inducing serum iron rebound.
    Type: Application
    Filed: September 6, 2017
    Publication date: April 12, 2018
    Inventors: George Tidmarsh, Lakhmir Chawla
  • METHODS OF ADMINISTERING HEPCIDIN
    Publication number: 20170246256
    Abstract: The present disclosure relates to the use of hepcidin in therapeutic methods for the treatment of various conditions in which decreasing serum iron concentration may be beneficial.
    Type: Application
    Filed: January 6, 2017
    Publication date: August 31, 2017
    Inventors: George Tidmarsh, Lakhmir Chawla
  • Methods for Administering Angiotensin II
    Publication number: 20170224761
    Abstract: The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
    Type: Application
    Filed: January 6, 2017
    Publication date: August 10, 2017
    Inventors: George Tidmarsh, Lakhmir Chawla
  • COMPOSITIONS AND METHODS RELATED TO GENTAMICIN
    Publication number: 20170218005
    Abstract: Various aspects of the invention relate to compositions comprising C-2a gentamicin. A composition may be substantially free from one or more of C-1 gentamicin, C-1a gentamicin, C-2 gentamicin, C-2b gentamicin, gentamicin A, gentamicin B, and gentamicin X. In some aspects, the invention relates to a method for treating a condition in a subject, comprising administering a composition comprising C-2a gentamicin to the subject. The condition may be, for example, a bacterial infection, genetic disease or disorder, or cancer.
    Type: Application
    Filed: January 27, 2017
    Publication date: August 3, 2017
    Inventors: George Tidmarsh, James Rolke, Lakhmir Chawla
  • Anti-Cancer Therapies
    Publication number: 20170157161
    Abstract: Methods for the treatment of cancer are described. In particular, methods for treatment of cancer comprising administration of glufosfamide alone or in combination with another anticancer agent are disclosed.
    Type: Application
    Filed: December 7, 2015
    Publication date: June 8, 2017
    Inventor: George Tidmarsh
  • COMPOSITIONS AND METHODS FOR ADMINISTERING GALECTIN ANTAGONISTS
    Publication number: 20170014446
    Abstract: The invention provides methods for the treatment of diseases and conditions relating to galectin 3 using a galectin-3 inhibitor, such as a modified pectin (e.g., GCS-100). Also described are methods for conjoint therapy, and methods for assessing and/or monitoring the effects of a galectin-3 inhibitor, e.g., to adapt the dosing regimen of the inhibitor during therapy.
    Type: Application
    Filed: March 10, 2015
    Publication date: January 19, 2017
    Applicant: LA JOLLA PHARMACEUTICAL COMPANY
    Inventors: James Rolke, George Tidmarsh
  • COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE
    Publication number: 20170014471
    Abstract: The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of renal failure, especially renal failure associated with cirrhosis.
    Type: Application
    Filed: September 30, 2016
    Publication date: January 19, 2017
    Inventor: George Tidmarsh
  • Compositions and methods for treating renal failure
    Patent number: 9457059
    Abstract: The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of renal failure, especially renal failure associated with cirrhosis.
    Type: Grant
    Filed: April 28, 2014
    Date of Patent: October 4, 2016
    Assignee: La Jolla Pharmaceutical Company
    Inventor: George Tidmarsh